Cargando…

Ultrasound‐guided percutaneous metal‐organic frameworks based codelivery system of doxorubicin/acetazolamide for hepatocellular carcinoma therapy

Detalles Bibliográficos
Autores principales: Jing, Ziwei, Wang, Xiaohui, Li, Na, Sun, Zhi, Zhang, Dingding, Zhou, Lin, Yin, Fanxiang, Jia, Qingquan, Wang, Mengli, Chu, Yaojuan, Du, Shuzhang, He, Yaping, Du, Qiuzheng, Zhang, Xiaojian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516336/
https://www.ncbi.nlm.nih.gov/pubmed/34709761
http://dx.doi.org/10.1002/ctm2.600
_version_ 1784583781796020224
author Jing, Ziwei
Wang, Xiaohui
Li, Na
Sun, Zhi
Zhang, Dingding
Zhou, Lin
Yin, Fanxiang
Jia, Qingquan
Wang, Mengli
Chu, Yaojuan
Du, Shuzhang
He, Yaping
Du, Qiuzheng
Zhang, Xiaojian
author_facet Jing, Ziwei
Wang, Xiaohui
Li, Na
Sun, Zhi
Zhang, Dingding
Zhou, Lin
Yin, Fanxiang
Jia, Qingquan
Wang, Mengli
Chu, Yaojuan
Du, Shuzhang
He, Yaping
Du, Qiuzheng
Zhang, Xiaojian
author_sort Jing, Ziwei
collection PubMed
description
format Online
Article
Text
id pubmed-8516336
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85163362021-10-21 Ultrasound‐guided percutaneous metal‐organic frameworks based codelivery system of doxorubicin/acetazolamide for hepatocellular carcinoma therapy Jing, Ziwei Wang, Xiaohui Li, Na Sun, Zhi Zhang, Dingding Zhou, Lin Yin, Fanxiang Jia, Qingquan Wang, Mengli Chu, Yaojuan Du, Shuzhang He, Yaping Du, Qiuzheng Zhang, Xiaojian Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-10-14 /pmc/articles/PMC8516336/ /pubmed/34709761 http://dx.doi.org/10.1002/ctm2.600 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Jing, Ziwei
Wang, Xiaohui
Li, Na
Sun, Zhi
Zhang, Dingding
Zhou, Lin
Yin, Fanxiang
Jia, Qingquan
Wang, Mengli
Chu, Yaojuan
Du, Shuzhang
He, Yaping
Du, Qiuzheng
Zhang, Xiaojian
Ultrasound‐guided percutaneous metal‐organic frameworks based codelivery system of doxorubicin/acetazolamide for hepatocellular carcinoma therapy
title Ultrasound‐guided percutaneous metal‐organic frameworks based codelivery system of doxorubicin/acetazolamide for hepatocellular carcinoma therapy
title_full Ultrasound‐guided percutaneous metal‐organic frameworks based codelivery system of doxorubicin/acetazolamide for hepatocellular carcinoma therapy
title_fullStr Ultrasound‐guided percutaneous metal‐organic frameworks based codelivery system of doxorubicin/acetazolamide for hepatocellular carcinoma therapy
title_full_unstemmed Ultrasound‐guided percutaneous metal‐organic frameworks based codelivery system of doxorubicin/acetazolamide for hepatocellular carcinoma therapy
title_short Ultrasound‐guided percutaneous metal‐organic frameworks based codelivery system of doxorubicin/acetazolamide for hepatocellular carcinoma therapy
title_sort ultrasound‐guided percutaneous metal‐organic frameworks based codelivery system of doxorubicin/acetazolamide for hepatocellular carcinoma therapy
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516336/
https://www.ncbi.nlm.nih.gov/pubmed/34709761
http://dx.doi.org/10.1002/ctm2.600
work_keys_str_mv AT jingziwei ultrasoundguidedpercutaneousmetalorganicframeworksbasedcodeliverysystemofdoxorubicinacetazolamideforhepatocellularcarcinomatherapy
AT wangxiaohui ultrasoundguidedpercutaneousmetalorganicframeworksbasedcodeliverysystemofdoxorubicinacetazolamideforhepatocellularcarcinomatherapy
AT lina ultrasoundguidedpercutaneousmetalorganicframeworksbasedcodeliverysystemofdoxorubicinacetazolamideforhepatocellularcarcinomatherapy
AT sunzhi ultrasoundguidedpercutaneousmetalorganicframeworksbasedcodeliverysystemofdoxorubicinacetazolamideforhepatocellularcarcinomatherapy
AT zhangdingding ultrasoundguidedpercutaneousmetalorganicframeworksbasedcodeliverysystemofdoxorubicinacetazolamideforhepatocellularcarcinomatherapy
AT zhoulin ultrasoundguidedpercutaneousmetalorganicframeworksbasedcodeliverysystemofdoxorubicinacetazolamideforhepatocellularcarcinomatherapy
AT yinfanxiang ultrasoundguidedpercutaneousmetalorganicframeworksbasedcodeliverysystemofdoxorubicinacetazolamideforhepatocellularcarcinomatherapy
AT jiaqingquan ultrasoundguidedpercutaneousmetalorganicframeworksbasedcodeliverysystemofdoxorubicinacetazolamideforhepatocellularcarcinomatherapy
AT wangmengli ultrasoundguidedpercutaneousmetalorganicframeworksbasedcodeliverysystemofdoxorubicinacetazolamideforhepatocellularcarcinomatherapy
AT chuyaojuan ultrasoundguidedpercutaneousmetalorganicframeworksbasedcodeliverysystemofdoxorubicinacetazolamideforhepatocellularcarcinomatherapy
AT dushuzhang ultrasoundguidedpercutaneousmetalorganicframeworksbasedcodeliverysystemofdoxorubicinacetazolamideforhepatocellularcarcinomatherapy
AT heyaping ultrasoundguidedpercutaneousmetalorganicframeworksbasedcodeliverysystemofdoxorubicinacetazolamideforhepatocellularcarcinomatherapy
AT duqiuzheng ultrasoundguidedpercutaneousmetalorganicframeworksbasedcodeliverysystemofdoxorubicinacetazolamideforhepatocellularcarcinomatherapy
AT zhangxiaojian ultrasoundguidedpercutaneousmetalorganicframeworksbasedcodeliverysystemofdoxorubicinacetazolamideforhepatocellularcarcinomatherapy